1 |
Tse GM, Tsang AK, Putti TC, et al (2005). Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours. J Clin Pathol, 58, 185-9.
DOI
|
2 |
Tse GMK, Lui PC, Vong JS, et al (2009). Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors. Breast Cancer Res Treat, 114, 441-8.
DOI
|
3 |
Yang X, Kandil D, Cosar EF, Khan A (2014). Fibroepithelial tumors of the breast: pathologic and immunohistochemical features and molecular mechanisms. Arch Pathol Lab Med, 138, 25-36.
DOI
|
4 |
Asif HM, Sultana S, Akhtar N, Rehman JU, Rehman RU (2014). Prevalence, risk factors and disease knowledge of breast cancer in Pakistan. Asian Pac J Cancer Prev, 15, 4411-6.
DOI
|
5 |
Asoglu O, Ugurlu MM, Blanchard K, et al (2004). Risk factors for recurrence and death after primary surgical treatment of malignant phyllodes tumors. Ann Surg Oncol, 11, 1011-7.
DOI
|
6 |
Al-Masri M, Darwazeh G, Sawalhi S, et al (2012). Phyllodes Tumor of the Breast: Role of CD10 in predicting metastasis. Ann Surg Oncol, 19, 1181-4.
DOI
|
7 |
Barth RJ Jr (1999). Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat, 57, 291-5.
DOI
|
8 |
Chen CM, Chen CJ, Chang CL, et al (2000). CD34, CD117 and actin expression in phyllodes tumor of the breast. J Surg Res, 94, 84-91.
DOI
|
9 |
Barth RJ Jr, Wells WA, Mitchell SE, Cole BF (2009). A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors. Ann Surg Oncol, 16, 2288-94.
DOI
|
10 |
Burton GV, Hart LL, Leight GS, et al (1989). Cystosarcoma phyllodes. Effective therapy with cisplatin and etoposide chemotherapy. Cancer, 63, 2088-92.
DOI
|
11 |
Chu P, Arber DA (2000). Paraffin section detection of CD10 in 505 non hematopoietic neoplasms. Am J Clin Pathol, 113, 374-82.
DOI
|
12 |
Chu PG, Arber DA, Weiss LM, Chang KL (2001). Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumours: an immunohistochemical comparison of 34 cases. Mod Pathol, 14, 465-471.
DOI
|
13 |
Gillette CE, Bobrow LG, Millis RR (1990) S100 protein in human mammary tissue: Immunoreactivity in breast carcinoma, including Paget's disease of the nipple and value as a marker of myoepithelial cells. J Pathol, 160, 19-24.
DOI
|
14 |
Gregory CD, Tursz T, Edwards CF, et al (1987). Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype. J Immunol, 139, 313-8.
|
15 |
Guelstein VI, Tchypysheva TA, Ermilova VD, Ljubimov AV (1993) Myoepithelial and basement membrane antigen and malignant human breast tumors. Int J Cancer, 53, 269-77.
DOI
|
16 |
Hawkins RE, Schofield JB, Wiltshaw E, et al (1992). Ifosfamide is an active drug for chemotherapy of metastatic cystosarcoma phyllodes. Cancer, 69, 2271-5.
DOI
|
17 |
Khurshid A, Faridi N, Arif AM, Naqvi H, Tahir M (2013). Breast lesions in adolescents and young women in Pakistan-a 5 year study of significance of early recognition. Asian Pac J Cancer Prev, 14, 3465-7.
DOI
|
18 |
Hussin H, Pailoor J, Cheng PS (2013). The role of CD10 immunohistochemistry in the grading of phyllodes tumor of the breast. J Interdiscipl Histopathol, 1, 195-203.
|
19 |
Khosravi-Shahi P (2011). Management of non-metastatic phyllodes tumors of the breast: review of the literature. Surg Oncol, 20, 143-8.
DOI
|
20 |
Khurshid A, Kayani N, Bhurgri Y (2006). Phylloides tumors in adolescent girls and young women in Pakistan. Asian Pac J Cancer Prev, 7, 563-6.
|
21 |
Millar EK, Beretov J, Marr P, et al (1999). Malignant phyllodes tumours of the breast display increased stromal p53 protein expression. Histopathology, 34, 491-6.
DOI
|
22 |
Moore MA, AriyaratneY, Badar F, et al (2009). Cancer epidemiology in South Asia past, present and future. Asian Pac J Cancer Prev, 10, 49-67.
|
23 |
Moritani S, Kushima R, Sugihara H, et al (2002). Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections. Mod Pathol, 15, 397-405.
DOI
|
24 |
Noguchi S, Motomura S, Inaji H, Imaoka S, Koyama H (1993). Clonal analysis of fibroadenoma and phyllodes tumor of the breast. Cancer Res, 53, 4071-4.
|
25 |
Ortega E, Aranda FI, Chulia MT, et al (2001). Phyllodes tumor of the breast with actin inclusions in stromal cells: diagnosis by fine-needle aspiration cytology. Diagn Cytopathol, 25, 115-7.
DOI
|
26 |
Rowell MD, Perry RR, Hsiu JG, Barranco SC (1993). Phyllodes tumors. Am J Surg, 165, 376-9.
DOI
|
27 |
Tan PH, Jayabaskar T, Yip G, et al (2005). P53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study. Mod Pathol, 18, 1527-34.
|
28 |
Shaukat U, Ismail M, Mehmood N (2013). Epidemiology, major risk factors and genetic predisposition for breast cancer in the Pakistani population. Asian Pac J Cancer Prev, 14, 625-9.
DOI
ScienceOn
|
29 |
Stein H, Lennert K, Feller AC, Mason DY (1984). Immunohistological analysis of human lymphoma: correlation of histological and immunological categories. Adv Cancer Res, 42, 67-147.
DOI
|
30 |
Tan PH, Jayabaskar T, Chuah KL, et al (2005). Phyllodes tumors of the breast: the role of pathologic parameters. Am J Clin Pathol, 123, 529-40.
DOI
|
31 |
Tan PH, Tse GM, Lee A (2013). WHO classification of Tumors of the Breast (4th edn). IARC Press, Lyon, France pp 142-7.
|
32 |
Tsai WC, Jin JS, Yu JC, Sheu LF (2006). CD10, actin, and vimentin expression in breast phyllodes tumors correlates with tumor grades of the WHO grading system. Int J Surg Pathol, 14, 127-31.
DOI
|
33 |
Tse GM, Lui PC, Scolyer RA, et al (2003). Tumour angiogenesis and p53 protein expression in mammary phyllodes tumours. Mod Pathol, 16, 1007-13.
DOI
|
34 |
Tse GMK, Lui PCW, Lee CS, et al (2004). Stromal expression of vascular endoethelial growth factor correlates with tumor grade and microvessel density in mammary phyllodes tumors: a multicenter study of 185 cases. Hum Pathol, 35, 1053-7.
DOI
|
35 |
Tse GM, Tan PH (2005). Recent advances in the pathology of fibroepithelial tumors of the breast. Curr Diagn Pathol, 11, 426-34.
DOI
|